Reuters logo
in 16 days
BRIEF-Impax announces FDA approval, launch of additional strengths of generic Focalin XR extended-release capsules CII
July 5, 2017 / 9:11 PM / in 16 days

BRIEF-Impax announces FDA approval, launch of additional strengths of generic Focalin XR extended-release capsules CII

1 Min Read

July 5 (Reuters) - Impax Laboratories Inc:

* Impax announces FDA approval and launch of additional strengths of generic Focalin XR® (dexmethylphenidate hydrochloride) extended-release capsules CII

* Impax Laboratories Inc - Impax has immediately initiated commercialization activities Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below